世界の未分画ヘパリン市場

QYResearchが発行した調査報告書(DATA909X17116)
◆英語タイトル:Global Unfractionated Heparin Market Professional Survey Report 2019
◆商品コード:DATA909X17116
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年11月22日(※2024年版があります。お問い合わせください)
◆ページ数:106
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:材料・化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、未分画ヘパリンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ウシ、ブタに、用途別には、病院、クリニック、その他にセグメント区分し、未分画ヘパリンの世界市場を分析しました。


・エグゼクティブ・サマリー
・未分画ヘパリンの世界市場概要
・未分画ヘパリンの製造コスト構成分析
・未分画ヘパリンの開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・未分画ヘパリンの地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・未分画ヘパリンのセグメント分析(種類別)
(ウシ、ブタ)
・未分画ヘパリンのセグメント分析(用途別)
(病院、クリニック、その他)
・未分画ヘパリンの主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Baxter International Inc.、B. Braun Melsungen AG、Fresenius SE & Co. KGaA、LEO Pharma A/S、Sagent Pharmaceuticals、Pfizer, Inc.、)
・未分画ヘパリンの市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

The global Unfractionated Heparin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Unfractionated Heparin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Unfractionated Heparin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Unfractionated Heparin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Unfractionated Heparin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Baxter International Inc.
B. Braun Melsungen AG
Fresenius SE & Co. KGaA
LEO Pharma A/S
Sagent Pharmaceuticals
Pfizer, Inc.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Bovine
Porcine

Segment by Application
Hospitals
Clinics
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Unfractionated Heparin
1.1 Definition of Unfractionated Heparin
1.2 Unfractionated Heparin Segment by Type
1.2.1 Global Unfractionated Heparin Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Bovine
1.2.3 Porcine
1.3 Unfractionated Heparin Segment by Applications
1.3.1 Global Unfractionated Heparin Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Unfractionated Heparin Overall Market
1.4.1 Global Unfractionated Heparin Revenue (2014-2025)
1.4.2 Global Unfractionated Heparin Production (2014-2025)
1.4.3 North America Unfractionated Heparin Status and Prospect (2014-2025)
1.4.4 Europe Unfractionated Heparin Status and Prospect (2014-2025)
1.4.5 China Unfractionated Heparin Status and Prospect (2014-2025)
1.4.6 Japan Unfractionated Heparin Status and Prospect (2014-2025)
1.4.7 Southeast Asia Unfractionated Heparin Status and Prospect (2014-2025)
1.4.8 India Unfractionated Heparin Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Unfractionated Heparin
2.3 Manufacturing Process Analysis of Unfractionated Heparin
2.4 Industry Chain Structure of Unfractionated Heparin

3 Development and Manufacturing Plants Analysis of Unfractionated Heparin
3.1 Capacity and Commercial Production Date
3.2 Global Unfractionated Heparin Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Unfractionated Heparin
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Unfractionated Heparin Production and Capacity Analysis
4.2 Unfractionated Heparin Revenue Analysis
4.3 Unfractionated Heparin Price Analysis
4.4 Market Concentration Degree

5 Unfractionated Heparin Regional Market Analysis
5.1 Unfractionated Heparin Production by Regions
5.1.1 Global Unfractionated Heparin Production by Regions
5.1.2 Global Unfractionated Heparin Revenue by Regions
5.2 Unfractionated Heparin Consumption by Regions
5.3 North America Unfractionated Heparin Market Analysis
5.3.1 North America Unfractionated Heparin Production
5.3.2 North America Unfractionated Heparin Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Unfractionated Heparin Import and Export
5.4 Europe Unfractionated Heparin Market Analysis
5.4.1 Europe Unfractionated Heparin Production
5.4.2 Europe Unfractionated Heparin Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Unfractionated Heparin Import and Export
5.5 China Unfractionated Heparin Market Analysis
5.5.1 China Unfractionated Heparin Production
5.5.2 China Unfractionated Heparin Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Unfractionated Heparin Import and Export
5.6 Japan Unfractionated Heparin Market Analysis
5.6.1 Japan Unfractionated Heparin Production
5.6.2 Japan Unfractionated Heparin Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Unfractionated Heparin Import and Export
5.7 Southeast Asia Unfractionated Heparin Market Analysis
5.7.1 Southeast Asia Unfractionated Heparin Production
5.7.2 Southeast Asia Unfractionated Heparin Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Unfractionated Heparin Import and Export
5.8 India Unfractionated Heparin Market Analysis
5.8.1 India Unfractionated Heparin Production
5.8.2 India Unfractionated Heparin Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Unfractionated Heparin Import and Export

6 Unfractionated Heparin Segment Market Analysis (by Type)
6.1 Global Unfractionated Heparin Production by Type
6.2 Global Unfractionated Heparin Revenue by Type
6.3 Unfractionated Heparin Price by Type

7 Unfractionated Heparin Segment Market Analysis (by Application)
7.1 Global Unfractionated Heparin Consumption by Application
7.2 Global Unfractionated Heparin Consumption Market Share by Application (2014-2019)

8 Unfractionated Heparin Major Manufacturers Analysis
8.1 Baxter International Inc.
8.1.1 Baxter International Inc. Unfractionated Heparin Production Sites and Area Served
8.1.2 Baxter International Inc. Product Introduction, Application and Specification
8.1.3 Baxter International Inc. Unfractionated Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 B. Braun Melsungen AG
8.2.1 B. Braun Melsungen AG Unfractionated Heparin Production Sites and Area Served
8.2.2 B. Braun Melsungen AG Product Introduction, Application and Specification
8.2.3 B. Braun Melsungen AG Unfractionated Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Fresenius SE & Co. KGaA
8.3.1 Fresenius SE & Co. KGaA Unfractionated Heparin Production Sites and Area Served
8.3.2 Fresenius SE & Co. KGaA Product Introduction, Application and Specification
8.3.3 Fresenius SE & Co. KGaA Unfractionated Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 LEO Pharma A/S
8.4.1 LEO Pharma A/S Unfractionated Heparin Production Sites and Area Served
8.4.2 LEO Pharma A/S Product Introduction, Application and Specification
8.4.3 LEO Pharma A/S Unfractionated Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Sagent Pharmaceuticals
8.5.1 Sagent Pharmaceuticals Unfractionated Heparin Production Sites and Area Served
8.5.2 Sagent Pharmaceuticals Product Introduction, Application and Specification
8.5.3 Sagent Pharmaceuticals Unfractionated Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Pfizer, Inc.
8.6.1 Pfizer, Inc. Unfractionated Heparin Production Sites and Area Served
8.6.2 Pfizer, Inc. Product Introduction, Application and Specification
8.6.3 Pfizer, Inc. Unfractionated Heparin Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Unfractionated Heparin Market
9.1 Global Unfractionated Heparin Market Trend Analysis
9.1.1 Global Unfractionated Heparin Market Size (Volume and Value) Forecast 2019-2025
9.2 Unfractionated Heparin Regional Market Trend
9.2.1 North America Unfractionated Heparin Forecast 2019-2025
9.2.2 Europe Unfractionated Heparin Forecast 2019-2025
9.2.3 China Unfractionated Heparin Forecast 2019-2025
9.2.4 Japan Unfractionated Heparin Forecast 2019-2025
9.2.5 Southeast Asia Unfractionated Heparin Forecast 2019-2025
9.2.6 India Unfractionated Heparin Forecast 2019-2025
9.3 Unfractionated Heparin Market Trend (Product Type)
9.4 Unfractionated Heparin Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Unfractionated Heparin Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Unfractionated Heparin
Table Global Unfractionated Heparin Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Unfractionated Heparin Production Market Share by Types in 2018
Figure Bovine Product Picture
Figure Porcine Product Picture
Table Global Unfractionated Heparin Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Unfractionated Heparin Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Other
Figure Global Unfractionated Heparin Revenue (Million USD) (2014-2025)
Figure Global Unfractionated Heparin Production (K MT) (2014-2025)
Figure North America Unfractionated Heparin Market Size (Million USD) (2014-2025)
Figure Europe Unfractionated Heparin Market Size (Million USD) (2014-2025)
Figure China Unfractionated Heparin Market Size (Million USD) (2014-2025)
Figure Japan Unfractionated Heparin Market Size (Million USD) (2014-2025)
Figure Southeast Asia Unfractionated Heparin Market Size (Million USD) (2014-2025)
Figure India Unfractionated Heparin Market Size (Million USD) (2014-2025)
Table Unfractionated Heparin Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Unfractionated Heparin in 2018
Figure Manufacturing Process Analysis of Unfractionated Heparin
Figure Industry Chain Structure of Unfractionated Heparin
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Unfractionated Heparin Manufacturing Plants Distribution
Table Unfractionated Heparin Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Unfractionated Heparin Capacity (K MT) of Major Manufacturers (2014-2019)
Table Unfractionated Heparin Production (K MT) of Major Manufacturers (2014-2019)
Table Unfractionated Heparin Production Market Share of Major Manufacturers (2014-2019)
Figure Unfractionated Heparin Production Share by Manufacturers in 2018
Table Unfractionated Heparin Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Unfractionated Heparin Revenue Market Share of Major Manufacturers (2014-2019)
Figure Unfractionated Heparin Revenue Share by Manufacturers in 2018
Table Unfractionated Heparin Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Unfractionated Heparin Production by Regions 2014-2019 (K MT)
Table Global Unfractionated Heparin Production Market Share by Regions 2014-2019
Figure Global Unfractionated Heparin Production Market Share by Regions in 2018
Table Global Unfractionated Heparin Revenue by Regions 2014-2019 (Million USD)
Table Global Unfractionated Heparin Revenue Market Share by Regions 2014-2019
Figure Global Unfractionated Heparin Revenue Market Share by Regions in 2018
Table Global Unfractionated Heparin Consumption by Regions 2014-2019 (K MT)
Table Global Unfractionated Heparin Consumption Market Share by Regions 2014-2019
Figure North America Unfractionated Heparin Production Growth Rate 2014-2019 (K MT)
Figure North America Unfractionated Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table North America Unfractionated Heparin Production, Consumption Import and Export (K MT)
Figure Europe Unfractionated Heparin Production Growth Rate 2014-2019 (K MT)
Figure Europe Unfractionated Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Unfractionated Heparin Production, Consumption Import and Export (K MT)
Figure China Unfractionated Heparin Production Growth Rate 2014-2019 (K MT)
Figure China Unfractionated Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table China Unfractionated Heparin Production, Consumption Import and Export (K MT)
Figure Japan Unfractionated Heparin Production Growth Rate 2014-2019 (K MT)
Figure Japan Unfractionated Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Unfractionated Heparin Production, Consumption Import and Export (K MT)
Figure Southeast Asia Unfractionated Heparin Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Unfractionated Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Unfractionated Heparin Production, Consumption Import and Export (K MT)
Figure India Unfractionated Heparin Production Growth Rate 2014-2019 (K MT)
Figure India Unfractionated Heparin Revenue Growth Rate 2014-2019 (Million USD)
Table India Unfractionated Heparin Production, Consumption Import and Export (K MT)
Figure Global Consumption Unfractionated Heparin Market Share by Application (2014-2019)
Figure Global Value (Consumption) Unfractionated Heparin Market Share by Application (2014-2019)
Table Baxter International Inc. Unfractionated Heparin Production Sites and Area Served
Table Baxter International Inc. Unfractionated Heparin Product Introduction, Application and Specification
Table Baxter International Inc. Unfractionated Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Baxter International Inc. Unfractionated Heparin Production Growth Rate (2014-2019)
Table Baxter International Inc. Unfractionated Heparin Production Market Share (2014-2019)
Figure Baxter International Inc. Unfractionated Heparin Revenue Market Share (2014-2019)
Table Baxter International Inc. Unfractionated Heparin Main Business and Markets Served
Table B. Braun Melsungen AG Unfractionated Heparin Production Sites and Area Served
Table B. Braun Melsungen AG Unfractionated Heparin Product Introduction, Application and Specification
Table B. Braun Melsungen AG Unfractionated Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table B. Braun Melsungen AG Unfractionated Heparin Production Growth Rate (2014-2019)
Table B. Braun Melsungen AG Unfractionated Heparin Production Market Share (2014-2019)
Figure B. Braun Melsungen AG Unfractionated Heparin Revenue Market Share (2014-2019)
Table B. Braun Melsungen AG Unfractionated Heparin Main Business and Markets Served
Table Fresenius SE & Co. KGaA Unfractionated Heparin Production Sites and Area Served
Table Fresenius SE & Co. KGaA Unfractionated Heparin Product Introduction, Application and Specification
Table Fresenius SE & Co. KGaA Unfractionated Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Fresenius SE & Co. KGaA Unfractionated Heparin Production Growth Rate (2014-2019)
Table Fresenius SE & Co. KGaA Unfractionated Heparin Production Market Share (2014-2019)
Figure Fresenius SE & Co. KGaA Unfractionated Heparin Revenue Market Share (2014-2019)
Table Fresenius SE & Co. KGaA Unfractionated Heparin Main Business and Markets Served
Table LEO Pharma A/S Unfractionated Heparin Production Sites and Area Served
Table LEO Pharma A/S Unfractionated Heparin Product Introduction, Application and Specification
Table LEO Pharma A/S Unfractionated Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table LEO Pharma A/S Unfractionated Heparin Production Growth Rate (2014-2019)
Table LEO Pharma A/S Unfractionated Heparin Production Market Share (2014-2019)
Figure LEO Pharma A/S Unfractionated Heparin Revenue Market Share (2014-2019)
Table LEO Pharma A/S Unfractionated Heparin Main Business and Markets Served
Table Sagent Pharmaceuticals Unfractionated Heparin Production Sites and Area Served
Table Sagent Pharmaceuticals Unfractionated Heparin Product Introduction, Application and Specification
Table Sagent Pharmaceuticals Unfractionated Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Sagent Pharmaceuticals Unfractionated Heparin Production Growth Rate (2014-2019)
Table Sagent Pharmaceuticals Unfractionated Heparin Production Market Share (2014-2019)
Figure Sagent Pharmaceuticals Unfractionated Heparin Revenue Market Share (2014-2019)
Table Sagent Pharmaceuticals Unfractionated Heparin Main Business and Markets Served
Table Pfizer, Inc. Unfractionated Heparin Production Sites and Area Served
Table Pfizer, Inc. Unfractionated Heparin Product Introduction, Application and Specification
Table Pfizer, Inc. Unfractionated Heparin Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer, Inc. Unfractionated Heparin Production Growth Rate (2014-2019)
Table Pfizer, Inc. Unfractionated Heparin Production Market Share (2014-2019)
Figure Pfizer, Inc. Unfractionated Heparin Revenue Market Share (2014-2019)
Table Pfizer, Inc. Unfractionated Heparin Main Business and Markets Served
Figure Global Unfractionated Heparin Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Unfractionated Heparin Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Unfractionated Heparin Sales Price (USD/MT) Forecast 2019-2025
Figure North America Unfractionated Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Unfractionated Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Unfractionated Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Unfractionated Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Unfractionated Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Unfractionated Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Unfractionated Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Unfractionated Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Unfractionated Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Unfractionated Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Unfractionated Heparin Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Unfractionated Heparin Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Unfractionated Heparin by Type (2019-2025)
Table Global Consumption (K MT) of Unfractionated Heparin by Application (2019-2025)
Table Unfractionated Heparin Distributors List
Table Unfractionated Heparin Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Baxter International Inc.、B. Braun Melsungen AG、Fresenius SE & Co. KGaA、LEO Pharma A/S、Sagent Pharmaceuticals、Pfizer, Inc.、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の未分画ヘパリン市場(Global Unfractionated Heparin Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。